Nautilus Biotechnology, Inc. (NAUT)
NASDAQ: NAUT · Real-Time Price · USD
2.700
+0.070 (2.66%)
At close: May 1, 2026, 4:00 PM EDT
2.734
+0.034 (1.26%)
After-hours: May 1, 2026, 7:44 PM EDT
Nautilus Biotechnology Employees
Nautilus Biotechnology had 130 employees as of December 31, 2025. The number of employees decreased by 25 or -16.13% compared to the previous year.
Employees
130
Change
-25
Growth
-16.13%
Revenue / Employee
n/a
Profits / Employee
-$439,115
Market Cap
341.72M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 130 | -25 | -16.13% |
| Sep 30, 2025 | 124 | -37 | -22.98% |
| Jun 30, 2025 | 128 | -36 | -21.95% |
| Mar 31, 2025 | 134 | -29 | -17.79% |
| Dec 31, 2024 | 155 | -12 | -7.19% |
| Sep 30, 2024 | 161 | 1 | 0.63% |
| Jun 30, 2024 | 164 | 11 | 7.19% |
| Mar 31, 2024 | 163 | 10 | 6.54% |
| Dec 31, 2023 | 167 | 33 | 24.63% |
| Sep 30, 2023 | 160 | 33 | 25.98% |
| Jun 30, 2023 | 153 | 29 | 23.39% |
| Mar 31, 2023 | 153 | 34 | 28.57% |
| Dec 31, 2022 | 134 | 21 | 18.58% |
| Sep 30, 2022 | 127 | 30 | 30.93% |
| Jun 30, 2022 | 124 | 35 | 39.33% |
| Mar 31, 2022 | 119 | 30 | 33.71% |
| Dec 31, 2021 | 113 | 56 | 98.25% |
| Sep 30, 2021 | 97 | 40 | 70.18% |
| Jun 30, 2021 | 89 | - | - |
| Mar 31, 2021 | 89 | - | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Cabaletta Bio | 156 |
| Silence Therapeutics | 88 |
| Rezolute | 75 |
| Immuneering | 53 |
| Compass Therapeutics | 39 |
| DiaMedica Therapeutics | 35 |
| Inhibikase Therapeutics | 35 |
NAUT News
- 5 days ago - Nautilus Biotechnology Earnings Call Transcript: Q1 2026 - Transcripts
- 5 days ago - Nautilus Biotechnology Reports First Quarter 2026 Financial Results - GlobeNewsWire
- 5 weeks ago - Nautilus Biotechnology Transcript: Investor Summit Virtual Conference - Transcripts
- 6 weeks ago - Nautilus Biotechnology Announces Baylor College of Medicine as First Early Access Program Customer for Voyager Platform - GlobeNewsWire
- 2 months ago - Nautilus Biotechnology Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Nautilus Biotechnology Earnings Call Transcript: Q4 2025 - Transcripts
- 2 months ago - Nautilus Biotechnology to Participate in the TD Cowen 46th Annual Health Care Conference - GlobeNewsWire
- 6 months ago - Nautilus Biotechnology Reports Successful Installation and Testing of its First Field Evaluation Unit at the Buck Institute for Research on Aging - GlobeNewsWire